Shegokar, Ranjita
CapnoPharm GmbH,
Germany
2025 Rank: 81140
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 504 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81140 | 95093 |
| Total Cites | 479 | 481 |
| H-index | 9 | 9 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 19 | 19 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 106 | 106 |
| Number of Single+First+Last Authored Papers | 62 | 62 |
| Total Cites to Single+First+Last Authored Papers | 324 | 324 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 454 | 456 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.05 |
| Self-Citation Percentage |
0.42%
|
|
Shegokar, Ranjita
Capnomed GmbH,
Germany
2024 Rank: 103716
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 667 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103716 | 121225 |
| Total Cites | 416 | 417 |
| H-index | 8 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 17 | 17 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 81 | 82 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 256 | 257 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 390 | 391 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.07 |
| Self-Citation Percentage |
0.24%
|
|
Shegokar, Ranjita
CapnoPharm GmbH,
Germany
2023 Rank: 73378
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 461 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73378 | 83004 |
| Total Cites | 468 | 478 |
| H-index | 9 | 9 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 20 | 20 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 124 | 125 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 285 | 287 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 421 | 428 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.12 |
| Self-Citation Percentage |
2.09%
|
|
Shegokar, Ranjita
Capnomed GmbH,
Germany
2022 Rank: 150396
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1104 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 150396 | 175642 |
| Total Cites | 367 | 373 |
| H-index | 8 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 72 | 74 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 214 | 216 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 342 | 347 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.07 |
| Self-Citation Percentage |
1.61%
|
|
Shegokar, Ranjita
Capnomed GmbH,
Germany
2021 Rank: 155087
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biotechnology
Rank in SubField 1: 1161 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 155087 | 163652 |
| Total Cites | 532 | 556 |
| H-index | 10 | 11 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 119 | 122 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 303 | 307 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 496 | 509 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.09 |
| Self-Citation Percentage |
4.32%
|
|
Shegokar, Ranjita
Freie Universität Berlin,
Germany
2020 Rank: 256600
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biotechnology
Rank in SubField 1: 1873 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 256600 | 282818 |
| Total Cites | 331 | 349 |
| H-index | 9 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 97 | 97 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 176 | 177 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 302 | 313 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.12 |
| Self-Citation Percentage |
5.16%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.